Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, M. E.
Right arrow Articles by Gilbert, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, M. E.
Right arrow Articles by Gilbert, R. E.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 11 2229-2239, Copyright © 1999 by American Diabetes Association

ARTICLES

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

ME Cooper, D Vranes, S Youssef, SA Stacker, AJ Cox, B Rizkalla, DJ Casley, LA Bach, DJ Kelly and RE Gilbert
Department of Medicine, University of Melbourne, Austin and Repatriation Medical Centre, West Heidelberg, Victoria, Australia. cooper@austin.unimelb.edu.au

It has been suggested that the cytokine vascular endothelial growth factor (VEGF) has an important role in the pathogenesis of diabetic retinopathy, but its role in nephropathy has not been clearly demonstrated. Assessment of VEGF, 125I-VEGF binding, and vascular endothelial growth factor receptor-2 (VEGFR-2) in the kidney was performed after 3 and 32 weeks of streptozotocin-induced diabetes. Gene expression of both VEGF and VEGFR-2 was assessed by Northern blot analysis and the localization of the ligand and receptor was examined by in situ hybridization. VEGF and VEGFR-2 protein were also evaluated by immunohistochemistry. Binding of the radioligand 125I-VEGF was evaluated by in vitro and in vivo autoradiography. Diabetes was associated with increased renal VEGF gene expression. VEGF mRNA and protein were localized to the visceral epithelial cells of the glomerulus and to distal tubules and collecting ducts in both diabetic and nondiabetic rats. Renal VEGFR-2 mRNA was increased after 3 weeks of diabetes but not in long-term diabetes. In situ hybridization and immunohistochemical studies revealed that glomerular endothelial cells were the major site of VEGFR-2 expression. In addition, VEGFR-2 gene expression was detected in cortical and renomedullary interstitial cells and on endothelial cells of peritubular capillaries. There was an increase in 125I-VEGF binding sites after 3 but not 32 weeks of diabetes. The major VEGF binding sites were in the glomeruli. 125I-VEGF binding was also observed in medullary rays and in the renal papillae. These studies indicate an early and persistent increase in renal VEGF gene expression in association with experimental diabetes. In addition, an early and transient increase in renal VEGF receptors was also observed in diabetic rats. These findings are consistent with a role for VEGF in mediating some of the changes observed in the diabetic kidney.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
C.-H. Ku, K. E. White, A. Dei Cas, A. Hayward, Z. Webster, R. Bilous, S. Marshall, G. Viberti, and L. Gnudi
Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice
Diabetes, October 1, 2008; 57(10): 2824 - 2833.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Hazarika, A. O. Dokun, Y. Li, A. S. Popel, C. D. Kontos, and B. H. Annex
Impaired Angiogenesis After Hindlimb Ischemia in Type 2 Diabetes Mellitus: Differential Regulation of Vascular Endothelial Growth Factor Receptor 1 and Soluble Vascular Endothelial Growth Factor Receptor 1
Circ. Res., October 26, 2007; 101(9): 948 - 956.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. J. Kelly, D. Buck, A. J. Cox, Y. Zhang, and R. E. Gilbert
Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F565 - F574.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. Liu, M. Morimoto, S. Kitajima, T. Koike, Y. Yu, H. Shiiki, M. Nagata, T. Watanabe, and J. Fan
Increased Expression of Vascular Endothelial Growth Factor in Kidney Leads to Progressive Impairment of Glomerular Functions
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2094 - 2104.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. Menne, J.-K. Park, N. Shushakova, M. Mengel, M. Meier, and D. Fliser
The Continuous Erythropoietin Receptor Activator Affects Different Pathways of Diabetic Renal Injury
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2046 - 2053.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. Nakagawa
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1665 - F1672.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. T. Lindenmeyer, M. Kretzler, A. Boucherot, S. Berra, Y. Yasuda, A. Henger, F. Eichinger, S. Gaiser, H. Schmid, M. P. Rastaldi, et al.
Interstitial Vascular Rarefaction and Reduced VEGF-A Expression in Human Diabetic Nephropathy
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1765 - 1776.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. S. Colombo, G. Menicucci, P. G. McGuire, and A. Das
Hepatocyte Growth Factor/Scatter Factor Promotes Retinal Angiogenesis through Increased Urokinase Expression
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1793 - 1800.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Buraczynska, P. Ksiazek, I. Baranowicz-Gaszczyk, and L. Jozwiak
Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 827 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
W. C. Aird
Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Circ. Res., February 2, 2007; 100(2): 174 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
F. I.V. Errera, L. H. Canani, M. E. R. Silva, E. Yeh, W. Takahashi, K. G. Santos, K. E.P. Souto, B. Tschiedel, I. Roisenberg, J. L. Gross, et al.
Functional Vascular Endothelial Growth Factor -634G>C SNP Is Associated With Proliferative Diabetic Retinopathy: A case-control study in a Brazilian population of European ancestry
Diabetes Care, February 1, 2007; 30(2): 275 - 279.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. P. Cohen, G. T. Lautenslager, E. Hud, E. Shea, A. Wang, S. Chen, and C. W. Shearman
Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F789 - F795.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. H. Sung, F. N. Ziyadeh, A. Wang, P. E. Pyagay, Y. S. Kanwar, and S. Chen
Blockade of Vascular Endothelial Growth Factor Signaling Ameliorates Diabetic Albuminuria in Mice
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3093 - 3104.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
L. Rosivall and J. Peti-Peterdi
Heterogeneity of the afferent arteriole--correlations between morphology and function
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2703 - 2707.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
E.-Y. Lee, C. H. Chung, J. H. Kim, H.-J. Joung, and S. Y. Hong
Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes
Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1496 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Ichinose, Y. Maeshima, Y. Yamamoto, M. Kinomura, K. Hirokoshi, H. Kitayama, Y. Takazawa, H. Sugiyama, Y. Yamasaki, N. Agata, et al.
2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice.
Diabetes, May 1, 2006; 55(5): 1232 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. Katavetin, T. Miyata, R. Inagi, T. Tanaka, R. Sassa, J. R. Ingelfinger, T. Fujita, and M. Nangaku
High Glucose Blunts Vascular Endothelial Growth Factor Response to Hypoxia via the Oxidative Stress-Regulated Hypoxia-Inducible Factor/Hypoxia-Responsible Element Pathway
J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1405 - 1413.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
Y. S. Kang, Y. G. Park, B. K. Kim, S. Y. Han, Y. H. Jee, K. H. Han, M. H. Lee, H. K. Song, D. R. Cha, S. W. Kang, et al.
Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.
J. Mol. Endocrinol., April 1, 2006; 36(2): 377 - 388.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
L. J N Jensen, L. Denner, B. F Schrijvers, R. G Tilton, R. Rasch, and A. Flyvbjerg
Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
J. Endocrinol., March 1, 2006; 188(3): 493 - 501.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, Y. Y. Sautin, O. Glushakova, B. Croker, M. A. Atkinson, C. C. Tisher, and R. J. Johnson
Uncoupling of Vascular Endothelial Growth Factor with Nitric Oxide as a Mechanism for Diabetic Vasculopathy
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 736 - 745.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. S. Rich
Genetics of Diabetes and Its Complications
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 353 - 360.
[Full Text] [PDF]

Home page
 J. Physiol.Home page
A. H. J. Salmon, C. R. Neal, D. O. Bates, and S. J. Harper
Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli
J. Physiol., January 1, 2006; 570(1): 141 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. M. Bohlender, S. Franke, G. Stein, and G. Wolf
Advanced glycation end products and the kidney
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F645 - F659.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Ichinose, Y. Maeshima, Y. Yamamoto, H. Kitayama, Y. Takazawa, K. Hirokoshi, H. Sugiyama, Y. Yamasaki, K. Eguchi, and H. Makino
Antiangiogenic Endostatin Peptide Ameliorates Renal Alterations in the Early Stage of a Type 1 Diabetic Nephropathy Model
Diabetes, October 1, 2005; 54(10): 2891 - 2903.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Ashraf, G. Mick, S. Meleth, H. Abdullatif, X. Wang, and K. McCormick
Effect of Insulin on Plasma Vascular Endothelial Growth Factor in Children with New-Onset Diabetes
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4920 - 4923.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Wolf, S. Chen, and F. N. Ziyadeh
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease: Podocyte Injury Comes of Age in Diabetic Nephropathy
Diabetes, June 1, 2005; 54(6): 1626 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
Endocr. Rev., December 1, 2004; 25(6): 971 - 1010.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. Thallas-Bonke, C. Lindschau, B. Rizkalla, L. A. Bach, G. Boner, M. Meier, H. Haller, M. E. Cooper, and J. M. Forbes
Attenuation of Extracellular Matrix Accumulation in Diabetic Nephropathy by the Advanced Glycation End Product Cross-Link Breaker ALT-711 via a Protein Kinase C-{alpha}-Dependent Pathway
Diabetes, November 1, 2004; 53(11): 2921 - 2930.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Chen, Y. Kasama, J. S. Lee, B. Jim, M. Marin, and F. N. Ziyadeh
Podocyte-Derived Vascular Endothelial Growth Factor Mediates the Stimulation of {alpha}3(IV) Collagen Production by Transforming Growth Factor-{beta}1 in Mouse Podocytes
Diabetes, November 1, 2004; 53(11): 2939 - 2949.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
D. R. Cha, Y. S. Kang, S. Y. Han, Y. H. Jee, K. H. Han, J. Y. Han, Y. S. Kim, and N. H. Kim
Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats
J. Endocrinol., October 1, 2004; 183(1): 183 - 194.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Shimizu, Y. Masuda, T. Mori, H. Kitamura, M. Ishizaki, Y. Sugisaki, and Y. Fukuda
Vascular Endothelial Growth Factor165 Resolves Glomerular Inflammation and Accelerates Glomerular Capillary Repair in Rat Anti-Glomerular Basement Membrane Glomerulonephritis
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2655 - 2665.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. Nakagawa, H. Y. Lan, H. J. Zhu, D.-H. Kang, G. F. Schreiner, and R. J. Johnson
Differential regulation of VEGF by TGF-{beta} and hypoxia in rat proximal tubular cells
Am J Physiol Renal Physiol, October 1, 2004; 287(4): F658 - F664.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
P. H. Lapchak, M. Melter, S. Pal, J. A. Flaxenburg, C. Geehan, M. H. Frank, D. Mukhopadhyay, and D. M. Briscoe
CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island
Am J Physiol Renal Physiol, September 1, 2004; 287(3): F512 - F520.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Wang, J. H. Kwak, S. I. Kim, Y. He, and M. E. Choi
Transforming Growth Factor-{beta}1 Stimulates Vascular Endothelial Growth Factor 164 via Mitogen-activated Protein Kinase Kinase 3-p38{alpha} and p38{delta} Mitogen-activated Protein Kinase-dependent Pathway in Murine Mesangial Cells
J. Biol. Chem., August 6, 2004; 279(32): 33213 - 33219.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Yamamoto, Y. Maeshima, H. Kitayama, S. Kitamura, Y. Takazawa, H. Sugiyama, Y. Yamasaki, and H. Makino
Tumstatin Peptide, an Inhibitor of Angiogenesis, Prevents Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy
Diabetes, July 1, 2004; 53(7): 1831 - 1840.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. R. DANESH and Y. S. KANWAR
Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy
FASEB J, May 1, 2004; 18(7): 805 - 815.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. Caramelo, Ma. V. Alvarez-Arroyo, S. Yague, Y. Suzuki, Ma. A. Castilla, L. Velasco, F. R. Gonzalez-Pacheco, and A. Tejedor
Cyclosporin A toxicity, and more: vascular endothelial growth factor (VEGF) steps forward
Nephrol. Dial. Transplant., February 1, 2004; 19(2): 285 - 288.
[Full Text] [PDF]

Home page
 HypertensionHome page
X. Zhang, M. Lassila, M. E. Cooper, and Z. Cao
Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors
Hypertension, February 1, 2004; 43(2): 276 - 281.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M. Pascariu, M. Bendayan, and L. Ghitescu
Correlated Endothelial Caveolin Overexpression and Increased Transcytosis in Experimental Diabetes
J. Histochem. Cytochem., January 1, 2004; 52(1): 65 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. Boner, A. J. Cox, D. J. Kelly, A. Tobar, J. Bernheim, R. G. Langham, M. E. Cooper, and R. E. Gilbert
Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?
Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2293 - 2299.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Y. Jiang, Z. He, B. L. King, T. Kuroki, D. M. Opland, K. Suzuma, I. Suzuma, K. Ueki, R. N. Kulkarni, C. R. Kahn, et al.
Characterization of Multiple Signaling Pathways of Insulin in the Regulation of Vascular Endothelial Growth Factor Expression in Vascular Cells and Angiogenesis
J. Biol. Chem., August 22, 2003; 278(34): 31964 - 31971.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Khamaisi, B. F. Schrijvers, A. S. De Vriese, I. Raz, and A. Flyvbjerg
The emerging role of VEGF in diabetic kidney disease
Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1427 - 1430.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Khamaisi, B. F. Schrijvers, A. S. De Vriese, I. Raz, and A. Flyvbjerg
The emerging role of VEGF in diabetic kidney disease
Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1427 - 1430.
[Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
T. Wendt, N. Tanji, J. Guo, B. I. Hudson, A. Bierhaus, R. Ramasamy, B. Arnold, P. P. Nawroth, S. F. Yan, V. D'Agati, et al.
Glucose, Glycation, and RAGE: Implications for Amplification of Cellular Dysfunction in Diabetic Nephropathy
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1383 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. M. Wendt, N. Tanji, J. Guo, T. R. Kislinger, W. Qu, Y. Lu, L. G. Bucciarelli, L. L. Rong, B. Moser, G. S. Markowitz, et al.
RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy
Am. J. Pathol., April 1, 2003; 162(4): 1123 - 1137.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. J. Sheetz and G. L. King
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
JAMA, November 27, 2002; 288(20): 2579 - 2588.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Flyvbjerg, F. Dagnaes-Hansen, A. S. De Vriese, B. F. Schrijvers, R. G. Tilton, and R. Rasch
Amelioration of Long-Term Renal Changes in Obese Type 2 Diabetic Mice by a Neutralizing Vascular Endothelial Growth Factor Antibody
Diabetes, October 1, 2002; 51(10): 3090 - 3094.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Flyvbjerg, B. F. Schrijvers, A. S. De Vriese, R. G. Tilton, and R. Rasch
Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E362 - E366.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D.-H. Kang, J. Kanellis, C. Hugo, L. Truong, S. Anderson, D. Kerjaschki, G. F. Schreiner, and R. J. Johnson
Role of the Microvascular Endothelium in Progressive Renal Disease
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 806 - 816.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. Chou, I. Suzuma, K. J. Way, D. Opland, A. C. Clermont, K. Naruse, K. Suzuma, N. L. Bowling, C. J. Vlahos, L. P. Aiello, et al.
Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States: A Possible Explanation for Impaired Collateral Formation in Cardiac Tissue
Circulation, January 22, 2002; 105(3): 373 - 379.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Santilli, A. Spagnoli, A. Mohn, S. Tumini, A. Verrotti, F. Cipollone, A. Mezzetti, and F. Chiarelli
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at Risk for Developing Persistent Microalbuminuria
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3871 - 3876.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. S. D. VRIESE, R. G. TILTON, C. C. STEPHAN, and N. H. LAMEIRE
Vascular Endothelial Growth Factor Is Essential for Hyperglycemia-Induced Structural and Functional Alterations of the Peritoneal Membrane
J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1734 - 1741.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Nakagami, R. Morishita, K. Yamamoto, S.-i. Yoshimura, Y. Taniyama, M. Aoki, H. Matsubara, S. Kim, Y. Kaneda, and T. Ogihara
Phosphorylation of p38 Mitogen-Activated Protein Kinase Downstream of Bax-Caspase-3 Pathway Leads to Cell Death Induced by High D-Glucose in Human Endothelial Cells
Diabetes, June 1, 2001; 50(6): 1472 - 1481.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
T. Baba, K. Shimada, S. Neugebauer, D. Yamada, S. Hashimoto, and T. Watanabe
The Oral Insulin Sensitizer, Thiazolidinedione, Increases Plasma Vascular Endothelial Growth Factor in Type 2 Diabetic Patients
Diabetes Care, May 1, 2001; 24(5): 953 - 954.
[Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
A. S. D. VRIESE, R. G. TILTON, M. ELGER, C. C. STEPHAN, W. KRIZ, and N. H. LAMEIRE
Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes
J. Am. Soc. Nephrol., May 1, 2001; 12(5): 993 - 1000.
[Abstract] [Full Text]